Topical retinoids in inflammatory acne: A retrospective, investigator-blinded, vehicle-controlled, photographic assessment

Clinical Therapeutics

Volumn 27, Issue 2, 2005, Pages 216-224

  Leyden, James J ^a,f   Shalita, Alan ^b   Thiboutot, Diane ^c   Washenik, Kenneth ^d   Webster, Guy ^e  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

^f HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adapalene; Inflammatory acne; Tazarotene; Topical retinoids

Indexed keywords

ADAPALENE; RETINOIC ACID; RETINOID; TAZAROTENE;

ACNE; ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; HUMAN; INFLAMMATION; MEDICAL ASSESSMENT; MONOTHERAPY; PHOTOGRAPHY; RETROSPECTIVE STUDY;

EID: 16244399537     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2005.02.009     Document Type: Article

References (15)

1. Kligman A.M. Pathogenesis of acne vulgaris. II. Histopathology of comeclones induced in the rabbit ear by human sebum Arch Dermatol 98 1968 58 66
2. Webster G.F., Berson D., and Stein L.F. Efficacy and tolerability of oncedaily tazarotene 0.1% gel versus once-daily tretinoin 0.025% gel in the treatment of facial acne vulgaris: Arandomized trial Cutis 67 Suppl 6 2001 4 9
3. Leyden J.J., Tanghetti E.A., and Miller B. Once-daily tazarotene 0.1% gel versus once-daily tretinoin 0.1% microsponge gel for the treatment of facial acne vulgaris: A doubleblind randomizedtrial Cutis 69 Suppl 2 2002 12 19
4. Webster G.F., Guenther L., and Poulin Y.P. A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of oncedaily tazarotene 0.1% gel and adapalene 0.1% gelfor the treatment of facial acne vulgaris Cutis 69 Suppl 2 2002 4 11
5. Anaheim, Calif Lowe N., Anderson N., and Draelos Z. Comparing the efficacy and tolerability of tazarotene 0.1% gel and tretinoin 0.025% gel in the treatment of facial acne vulgaris: A second multicenter, double-blind, randomized trial Poster presented at: 59th Annual Meeting of the American Academy of Dermatology July 28-August 1, 2001
6. Shalita A., Weiss J.S., and Chalker D.K. A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: A multicenter trial J Am Acad Dermatol 34 1996 482 485
7. Anaheim, Calif Shalita A.R., Berson D.S., and Thiboutot D.M. Tazarotene cream in the treatment of acne Poster presented at: 59th Annual Meeting of the American Academy of Dermatology July 28-August 1, 2001
8. Leyden J., Lowe N., Kakita L., and Draelos Z. Comparison of treatment of acne vulgaris with alternate-day applications of tazarotene 0.1% gel and once-daily applications of adapalene 0.1% gel: A randomized trial Cutis 67 Suppl 6 2001 10 16
9. Allen B.S., and Smith J.G. Jr Various parameters for grading acne vulgaris Arch Dermatol 118 1982 23 25
10. Walker G.A. Common Statistical Methods for Clinical Research with SAS Examples 2nd ed. 2002 SAS Institute Inc Cary, NC
11. Cohen J. Statistical Power Analysis for the Behavioral Sciences 2nd ed. 1988 Lawrence Erlbaum Hillsdale, NJ
12. Bouclier M., Luginbuhl B., Shroot B., and Hensby C.N. Arachidonic acid induced ear oedema in four strains of rats and mice: A comparative study of anti-inflammatory drugs Agents Actions 29 1990 62 64
13. (Suppl) Shroot B., and Michel S. Pharmacology and chemistry of adapalene J Am Acad Dermatol 36 1997 S96 S103
14. San Francisco, Calif Vega B., Feret C., Jomard A., and Michel S. Toll-like receptor-2: A novel mechanism of action of adapalene in the treatment of inflammatory acne lesions Poster presented at: 61st Annual Meeting of the American Academy of Dermatology March 21-26, 2003
15. Kim J., Ochoa M.T., and Krutzik S.R. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses J Immunol 169 2002 1535 1541